Dominik Wolf‎

ORCID: 0000-0002-4761-075X · 2 papers in corpus · active 2020-2023

Study types

  • article 1
article 2023
Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study
·doi:10.1016/s0140-6736(22)02036-0
2020
High RIG-I expression in ovarian cancer associates with an immune-escape signature and poor clinical outcome.
International journal of cancer ·doi:10.1002/ijc.32818

Ovarian cancer (OC) is the most lethal gynecological malignancy, with platinum-based chemotherapy remaining the mainstay for adjuvant treatment after surgery. The lack of indication for immunotherapy may at least in part result from the lac…